• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. Assessment of fluoroquinolone resistance among pulmonary tuberculosis patients

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Assessment of fluoroquinolone resistance among pulmonary tuberculosis patients

    Author

    • Harish Chander Marwah
,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Background:Tuberculosis is most commonly found among people living in poor
conditions and in deprived areas, especially in elderly people and those with unstable
social or psychiatric backgrounds, such as hostel dwellers, street dwellers, alcoholics,
and drug misusers, as well as in immunocompromised patients.The present study was
conducted to assess fluoroquinolone resistance among pulmonary tuberculosis patients.
Materials & Methods:58 pulmonary TB patients of both genders were included. All
patients were subjected to DST for first-line drugs (FLDs) and second-line drugs. FQs
DST was also performed using automated Mycobacterial Growth Indicator Tube-960
liquid culture technique. The immunochromatographic assay was performed to
distinguish Mycobacterium tuberculosis complex (MTBC) from non-MTBC
Results: Out of 58, males were 38and females were 20. One drug resistance such as
Ofloxacin was seen in 28, levofloxacin in 3 cases, moxifloxacin in 1 and Kanamycin in 1
case. Two drug resistance such as Kanamycin+ Ofloxacin in 2 and Levofloxacin+
Ofloxacin in 1 case. Three drug resistance such as Ofloxacin+
Levofloxacin+Moxifloxacin in 1 and Ofloxacin+ Levofloxacin+ Kanamycin in 1 case and
all sensitive isolates was seen in Ofloxacin+ Levofloxacin+ Kanamycin+ Moxifloxacin in
20 cases. The difference was significant (P< 0.05).
Conclusion: Fluoroquinolone resistance among drug sensitive and multidrug resistance
tuberculosis isolates was high

Keywords

  • Fluoroquinolone
  • pulmonary tuberculosis
  • Ofloxacin
  • XML
  • PDF 210.04 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 97
    • PDF Download: 206
European Journal of Molecular & Clinical Medicine
Volume 9, Issue 3
February 2022
Page 1624-1628
Files
  • XML
  • PDF 210.04 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 97
  • PDF Download: 206

APA

Marwah, H. C. (2022). Assessment of fluoroquinolone resistance among pulmonary tuberculosis patients. European Journal of Molecular & Clinical Medicine, 9(3), 1624-1628.

MLA

Harish Chander Marwah. "Assessment of fluoroquinolone resistance among pulmonary tuberculosis patients". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 1624-1628.

HARVARD

Marwah, H. C. (2022). 'Assessment of fluoroquinolone resistance among pulmonary tuberculosis patients', European Journal of Molecular & Clinical Medicine, 9(3), pp. 1624-1628.

VANCOUVER

Marwah, H. C. Assessment of fluoroquinolone resistance among pulmonary tuberculosis patients. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 1624-1628.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus